← Insider buys
CHRS

Coherus Oncology, Inc. · Healthcare

Director James Healy sold $7.3M of Coherus Oncology, Inc.

Sold$7,250,063
$16.68Price
434,555Shares
−86%Stake

What CHRS did after the filing

Prices for CHRS after this filing aren't in yet.

Traded Mon, Sep 27. Filed Wed, Sep 29, 8:18 PM ET, after the close. Not investment advice.